Decrease in hepatic cytochrome P450 after interleukin-2 immunotherapy.
Elkahwaji J, Robin MA, Berson A, Tinel M, Lettéron P, Labbe G, Beaune P, Elias D, Rougier P, Escudier B, Duvillard P, Pessayre D.
Elkahwaji J, et al. Among authors: robin ma.
Biochem Pharmacol. 1999 Apr 15;57(8):951-4. doi: 10.1016/s0006-2952(98)00372-4.
Biochem Pharmacol. 1999.
PMID: 10086330
Clinical Trial.